commure.comHealthcare / Healthcare softwareFounded: 2017Funding to Date: $2.34B
Commure, founded in 2017, is a healthcare operating system built for hospitals and health systems. Commure is aiming to improve the experiences of healthcare providers by connecting datasets and digital solutions through a suite of applications thus enabling providers to collaborate more seamlessly.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
10/03/2023 | Series ATH A-1 | $99,994.34 | $xx.xx | $3.35B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
30,421
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/03/2023 | Series ATH A-5 | $99,998.72 | $xx.xx | $3.35B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
153,974
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
7.9%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/03/2023 | Series ATH A-3 | $119,997.45 | $xx.xx | $3.35B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
152,110
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/03/2023 | Series ATH B-1 Prime | $324,853.75 | $xx.xx | $3.35B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
12,061
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/03/2023 | Series ATH B-1 | $1.52MM | $xx.xx | $3.35B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
161,887
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/03/2023 | Series ATH A-2 | $2.05MM | $xx.xx | $3.35B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
779,572
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/03/2023 | Series ATH A-4 | $3.19MM | $xx.xx | $3.35B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,852,728
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/03/2023 | Series ATH A | $14MM | $xx.xx | $3.35B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,482,607
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/03/2023 | Series ATH B Prime | $59.11MM | $xx.xx | $3.35B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,048,472
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/03/2023 | Series ATH B-2 | $60MM | $xx.xx | $3.35B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,659,485
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/03/2023 | Series ATH B | $72MM | $xx.xx | $3.35B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,673,139
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
09/16/2021 | Series D | $250MM | $xx.xx | $3.55B | Greenoaks Capital, Human Capital | |
Price per Share
$xx.xx
Shares Outstanding
3,121,655
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Greenoaks Capital, Human Capital
|
||||||
11/19/2020 | Series C-1 | $24.25MM | $xx.xx | $1.49B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,379,061
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
11/19/2020 | Series C | $351.69MM | $xx.xx | $1.49B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
10,485,132
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
04/12/2019 | Series B-1 | $28.3MM | $xx.xx | $271.64MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,556,202
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
06/05/2018 | Series B | $31.25MM | $xx.xx | $121.4MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,924,665
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
12/27/2017 | Series A | $12MM | $xx.xx | $22.93MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,907,896
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
12/27/2017 | Series A-1 | $12MM | $xx.xx | $22.93MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,907,896
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
09/19/2017 | Series Seed | $2MM | $xx.xx | $4MM | General Catalyst | |
Price per Share
$xx.xx
Shares Outstanding
2,559,835
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
General Catalyst
|
||||||
09/19/2017 | Series Seed-1 | $2MM | $xx.xx | $4MM | General Catalyst | |
Price per Share
$xx.xx
Shares Outstanding
2,559,835
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
General Catalyst
|